Evidence map›Paper›PMID 25888554›Full record

ArticleEukaryotic cell2015

Trypanosoma brucei Bloodstream Forms Depend upon Uptake of myo-Inositol for Golgi Complex Phosphatidylinositol Synthesis and Normal Cell Growth.

Amaia González-Salgado, Michael Steinmann, Louise L Major, Erwin Sigel, Jean-Louis Reymond, Terry K Smith, Peter Bütikofer

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. ITPK1 mediates the lipid-independent synthesis of inositol phosphates controlled by metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  6. Article
  7. Lipidomics and anti-trypanosomatid chemotherapy.Clinical and translational medicine · 2017
    Review
  8. HJournal of bioenergetics and biomembranes · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Lipid topogenesis--35years on.Biochimica et biophysica acta · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Amaia González-SalgadoInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Michael SteinmannInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Louise L MajorBiomedical Sciences Research Complex, University of St Andrews, North Haugh, St. Andrews, Fife, United Kingdom.
Erwin SigelInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Jean-Louis ReymondDepartment of Chemistry and Biochemistry, University of Bern, Bern, Switzerland.
Terry K SmithBiomedical Sciences Research Complex, University of St Andrews, North Haugh, St. Andrews, Fife, United Kingdom tks1@st-andrews.ac.uk peter.buetikofer@ibmm.unibe.ch.
Peter BütikoferInstitute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland tks1@st-andrews.ac.uk peter.buetikofer@ibmm.unibe.ch.
University of Bern · CHUniversity of St Andrews · GB

Funding

Wellcome TrustWellcome Trust 093228
6 · The paper itself

Abstract

myo-Inositol is a building block for all inositol-containing phospholipids in eukaryotes. It can be synthesized de novo from glucose-6-phosphate in the cytosol and endoplasmic reticulum. Alternatively, it can be taken up from the environment via Na(+)- or H(+)-linked myo-inositol transporters. While Na(+)-coupled myo-inositol transporters are found exclusively in the plasma membrane, H(+)-linked myo-inositol transporters are detected in intracellular organelles. In Trypanosoma brucei, the causative agent of human African sleeping sickness, myo-inositol metabolism is compartmentalized. De novo-synthesized myo-inositol is used for glycosylphosphatidylinositol production in the endoplasmic reticulum, whereas the myo-inositol taken up from the environment is used for bulk phosphatidylinositol synthesis in the Golgi complex. We now provide evidence that the Golgi complex-localized T. brucei H(+)-linked myo-inositol transporter (TbHMIT) is essential in bloodstream-form T. brucei. Downregulation of TbHMIT expression by RNA interference blocked phosphatidylinositol production and inhibited growth of parasites in culture. Characterization of the transporter in a heterologous expression system demonstrated a remarkable selectivity of TbHMIT for myo-inositol. It tolerates only a single modification on the inositol ring, such as the removal of a hydroxyl group or the inversion of stereochemistry at a single hydroxyl group relative to myo-inositol.

Indexed as

AnimalsGolgi ApparatusInositolPhosphatidylinositolsProtozoan ProteinsSymportersTrypanosoma brucei bruceiXenopusInositolPhosphatidylinositolsProtozoan ProteinsSymporters

Identifiers

PMID25888554
PMCPMC4452569
OpenAlexW2156986455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.